- Home
- KROS vs WASH Comparison
KROS vs WASH Comparison
Compare KROS & WASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- WASH
- Stock Information
- Founded
- KROS 2015
- WASH 1800
- Country
- KROS United States
- WASH United States
- Employees
- KROS N/A
- WASH N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- WASH Major Banks
- Sector
- KROS Health Care
- WASH Finance
- Exchange
- KROS Nasdaq
- WASH Nasdaq
- Market Cap
- KROS 460.6M
- WASH 623.4M
- IPO Year
- KROS 2020
- WASH N/A
- Fundamental
- Price
- KROS $11.13
- WASH $33.05
- Analyst Decision
- KROS Buy
- WASH Hold
- Analyst Count
- KROS 11
- WASH 2
- Target Price
- KROS $45.33
- WASH $34.00
- AVG Volume (30 Days)
- KROS 2.1M
- WASH 205.0K
- Earning Date
- KROS 02-26-2025
- WASH 01-29-2025
- Dividend Yield
- KROS N/A
- WASH 6.78%
- EPS Growth
- KROS N/A
- WASH N/A
- EPS
- KROS N/A
- WASH N/A
- Revenue
- KROS $651,000.00
- WASH $98,251,000.00
- Revenue This Year
- KROS $303.27
- WASH N/A
- Revenue Next Year
- KROS N/A
- WASH $10.09
- P/E Ratio
- KROS N/A
- WASH N/A
- Revenue Growth
- KROS 8037.50
- WASH N/A
- 52 Week Low
- KROS $9.78
- WASH $24.11
- 52 Week High
- KROS $73.00
- WASH $40.59
- Technical
- Relative Strength Index (RSI)
- KROS 25.01
- WASH 57.53
- Support Level
- KROS $11.04
- WASH $31.49
- Resistance Level
- KROS $11.36
- WASH $32.89
- Average True Range (ATR)
- KROS 0.53
- WASH 0.90
- MACD
- KROS 1.15
- WASH 0.25
- Stochastic Oscillator
- KROS 37.80
- WASH 93.64
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About WASH Washington Trust Bancorp Inc.
Washington Trust Bancorp Inc through its subsidiaries offers banking and financial services to individuals and businesses. It operates in two segments. The Commercial Banking segment includes lending activities, commercial loans, residential real estate loan deposit activities, and others. The Wealth Management Services segment consists of investment management, financial planning, personal trust, and estate services including services as trustee, personal representative, custodian and guardian, and settlement of decedents' estates. The bank generates a majority of its revenue from the Commercial Banking segment.